SILO PHARMA, INC. Increase (Decrease) in Prepaid Expenses, Other
SILO PHARMA, INC. (SILO) reported Increase (Decrease) in Prepaid Expenses, Other of $90.07 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2023-03-24
- SILO PHARMA, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2020-12-31 was $76.62K.
- SILO PHARMA, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2020-09-30 was $28.63K.
- SILO PHARMA, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2020-06-30 was $26.38K.
- SILO PHARMA, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2020-03-31 was $13.03K, a 107.65% increase year-over-year.
- SILO PHARMA, INC. increase (decrease) in prepaid expenses, other for fiscal 2022 was $90.07K.
- SILO PHARMA, INC. increase (decrease) in prepaid expenses, other for fiscal 2020 was $144.66K.
- SILO PHARMA, INC. increase (decrease) in prepaid expenses, other for fiscal 2019 was -$17.70K.
- SILO PHARMA, INC. increase (decrease) in prepaid expenses, other for fiscal 2018 was -$22.89K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|
| 2022-12-31 | $90.07K 10-K · filed 2023-03-24 | |||
| 2020-12-31 | $76.62K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | $105.25K derived: sum of 2 quarters · filed 2021-05-17 | $131.63K derived: sum of 3 quarters · filed 2021-05-17 | $144.66K 10-K/A · filed 2021-05-17 |
| 2020-09-30 | $28.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $55.01K derived: sum of 2 quarters · filed 2020-11-05 | $68.05K 10-Q · filed 2020-11-05 | $60.82K derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-06-30 | $26.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $39.41K 10-Q · filed 2020-08-14 | $32.19K derived: sum of 3 quarters · filed 2021-05-17 | $16.33K derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-03-31 | $13.03K 10-Q · filed 2020-05-12 | $5.81K derived: sum of 2 quarters · filed 2021-05-17 | -$10.05K derived: sum of 3 quarters · filed 2021-05-17 | -$10.94K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | -$7.23K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | -$23.08K derived: sum of 2 quarters · filed 2021-05-17 | -$23.98K derived: sum of 3 quarters · filed 2021-05-17 | -$17.70K 10-K/A · filed 2021-05-17 |
| 2019-09-30 | -$15.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$16.75K derived: sum of 2 quarters · filed 2020-11-05 | -$10.47K 10-Q · filed 2020-11-05 | -$11.46K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$891.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $5.39K 10-Q · filed 2020-08-14 | $4.39K derived: sum of 3 quarters · filed 2020-08-14 | -$6.40K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $6.28K 10-Q · filed 2020-05-12 | $5.29K derived: sum of 2 quarters · filed 2020-05-12 | -$5.51K derived: sum of 3 quarters · filed 2020-05-12 | -$16.31K derived: sum of 4 quarters · filed 2020-05-12 |
| 2018-12-31 | -$991.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | -$11.79K derived: sum of 2 quarters · filed 2020-03-20 | -$22.59K derived: sum of 3 quarters · filed 2020-03-20 | -$22.89K 10-K · filed 2020-03-20 |
| 2018-09-30 | -$10.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$21.60K derived: sum of 2 quarters · filed 2019-11-13 | -$21.90K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$10.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$11.10K 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | -$299.00 10-Q · filed 2019-05-14 | |||
| 2017-12-31 | -$408.00 10-K · filed 2019-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |